Aspira Women's Health Secures Reimbursement for Ova1Plus(R) from California Medicaid (Medi-Cal)GlobeNewsWire • 11/28/23
Aspira Women's Health Receives Final Crosswalk Pricing Determination from the Centers for Medicare & Medicaid Services (CMS)GlobeNewsWire • 11/27/23
Aspira Women's Health Supports Centers for Medicare & Medicaid Services (CMS) Proposed Rule to Crosswalk Medicare Reimbursement Rate for OvaWatchGlobeNewsWire • 11/09/23
Aspira Women's Health Sees Poster on its miRNA-based Ovarian Cancer Test Presented at the AACR Special Conference in Cancer ResearchGlobeNewsWire • 10/25/23
Is Aspira Women's Health (AWH) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 09/14/23
Aspira Women's Health Signs Exclusive Sample Procurement Agreement with The University of OxfordGlobeNewsWire • 08/31/23
Aspira Women's Health Announces Michelle Snider as Senior Vice President, Commercial Strategy and OperationsGlobeNewsWire • 08/28/23
Aspira Women's Health Announces Transition of its Chief Scientific Officer/Chief Operating OfficerGlobeNewsWire • 08/09/23
Aspira Women's Health to Announce Second Quarter Earnings Results and Host a Conference Call on Monday, August 14, 2023GlobeNewsWire • 07/31/23
Aspira Women's Health Regained Compliance with Nasdaq's Minimum Bid Price RequirementGlobeNewsWire • 06/02/23
Aspira Women's Health Announces the Publication of Three Abstracts by the American Society of Clinical Oncology (ASCO) Supporting the Clinical Utility of OvaSuite(SM) Ovarian Cancer Risk Assessment TestsGlobeNewsWire • 05/31/23
Aspira Women's Health to Participate at William Blair's 43rd Annual Growth Stock ConferenceGlobeNewsWire • 05/30/23
Aspira Women's Health to Present at the 2023 American College of Obstetricians and Gynecologists Annual Clinical & Scientific ConferenceGlobeNewsWire • 05/19/23
Aspira Women's Health to Host Investor Day on OvaWatch(SM) and EndoCheck™ Market Opportunities on May 23, 2023GlobeNewsWire • 05/15/23